The stress tests equipment market size is projected to be valued at US$ 2.41 Billion in 2022 and is expected to rise to US$ 4.21 Billion by 2032. The sales of stress tests equipment are expected to grow at a significant CAGR of 7.00% during the forecast period. Some of the factors propelling the sales of stress tests equipment are:
Attributes | Details |
---|---|
Stress Tests Equipment Market Value (2022) | US$ 2.14 Billion |
Stress Tests Equipment Market Forecast Value (2032) | US$ 4.21 Billion |
Stress Tests Equipment Market CAGR (2022 to 2032) | 7.00% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Recent developments in artificial intelligence and wearable technologies offer exceptional prospects to expand the use of these tests and simplify their interpretation.
The market will grow as a result of the presence of several exercise testing systems by significant key companies with numerous benefits and improvements. For instance, MGC Diagnostics Corporation offers the Ergocard CPX exercise testing system, which includes bronchial provocation testing software, diagnostic functions, full program control, and complete basic spirometry measurement. It also has quality control automated software, diagnostic functions, and full program control. The availability of such cutting-edge items will enable the segment to considerably contribute to market expansion.
Due to the precision and short running times of these devices, the exercise testing systems claim a considerable market share. Yet another factor in the rise in adoption of these systems, which is boosting the market's expansion, is the rising preference among doctors and patients due to their affordability and the variety of applications for these devices.
The most used cardiac screening test is Exercise Cardiac Stress testing (EST). The speed and height of the treadmill are gradually increased while the patient exercises on one in accordance with a set routine. The patient's ECG, heart rate, heart rhythm, and blood pressure are continually analyzsed throughout the exercise cardiac stress test (EST).
‘Stress’ is a word heard all too much in the fast paced, hectic lives that we all lead today. But what exactly is stress? In simple terms, it’s just a way for the body to respond to any kind of threat, either real or perceived. Stress hormones like adrenalin and cortisol are released by the nervous system, which prepare the body to either fight or take flight! A moderate amount of stress is actually good, contradictory as that may seem.
It keeps you alert at work, focused on winning a game or even motivates you to study when a crucial exam is approaching! However, when a person’s physical and mental well-being is threatened by their high stress levels, medication of some sort is required.
That’s where the stress test equipment market comes into picture. A stress test helps find out if a person has arrhythmia, if breathing problems faced are heart-related, how much they should exercise, or even to see if heart disease treatments are working. It is done by making a person walk on a treadmill to measure the heart rate, breathing, BP and the electrocardiogram
‘Prevention is better than cure’ is one of the most famous proverbs that cannot be more apt anywhere but in the drivers of the stress test equipment market. An aging population in the developed world, increasing prevalence of cardiac and breathing disorders due to rising pollution levels in the developing world all contribute to the growth of the stress test equipment market.
Even new hospitals constructed would definitely be responsible for increase in the demand. In 2014, more than a third of all deaths worldwide could be linked to cardiovascular diseases as per an estimate by the American Heart Association. Increasing awareness by the general public and also various government initiatives to educate people about various treatments available is expected to only grow the demand for this product and the whole market.
It would seem that all factors point to an increasing level of stress and thus an ever-growing market to check or control it. However, the stress test equipment market also has a few restraints challenging its growth which must be mentioned. Acts such as the Affordable Care Act, encourages the healthcare sector to provide cost-effective treatment to their patients.
This also makes them seriously reconsider investing in expensive stress test equipment. This becomes a much larger problem in the developing world, since the funds available with hospitals or the private sector there is much lower.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The Stress Tests Equipment market key regions correspond to the various geographic divisions i.e. North America, Europe, Asia- Pacific, Latin America, Middle East and North Africa (MENA) and the rest of the world (RoW). North America is currently the largest market because they have the most medical professionals and also some of the highest stress levels (hence greater awareness of the tests).
However, Asia- Pacific and in particular China is fast catching up in this category. Rising levels of air pollution have increased the occurrence of both respiratory and cardiovascular issues in this fast growing region, fuelling the long-term growth prospects of the stress test equipment market.
Thermo Fisher Scientific Ltd., Philips healthcare, Cardinal Health, Care Medical Ltd., Cosmed Medical, Cardiac Science Corporation and GE Healthcare are some of the stress tests equipment market key market players. Most of the companies are based in North America, since it is currently the largest stress test equipment market.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, types and applications.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The market is likely to register a CAGR of 7% through 2032.
The market is currently valued at US$ 2.14 Bn in 2022.
The market is likely to grow to a valuation of US$ 421 Bn by 2032.
Asia Pacific is likely to be a leading market during the forecast period.
Explore Healthcare Insights
View Reports